Recent Press Releases

BioTime Announces Dual Listing on the Tel Aviv Stock Exchange

ALAMEDA, Calif. & TEL AVIV, Israel--()--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company focused on the development and commercialization of cell-based therapies, announced...

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

CAMBRIDGE, Mass.--()--Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced the completion of an additional $17.6 million round...

Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies

MENLO PARK, Calif., (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the publication of two papers in The New England Journal of Medicine (NEJM) in which the company's...

Atopix Appoints Dr Andrew Zambanini As Chief Medical Officer

Atopix Therapeutics Limited ("Atopix"), a UK biotechnology company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announces the appointment of Dr...

Acadia (ACAD) Appoints Steve Davis as CEO

ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system...

AmpliPhi Biosciences Corporation (APHB) Announces Appointment Of Alexander Gaidamaka As Vice President Of Chemistry, Manufacturing And Control

San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, September 2, 2015 – AmpliPhi Biosciences Corporation (NYSE: APHB), a global leader in developing bacteriophage-based...

StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs

SAN DIEGO, Sept. 3, 2015 /PRNewswire/ -- StemProtein LLC, a leading manufacturer of stem cell factors, and a recent spinout of Stemedica Cell Technologies Inc., announced today that it appoints...

Faraday Pharmaceuticals Announces The Appointment Of Dr. Stephen A. Hill As Chief Executive Officer

SEATTLE, Sept. 3, 2015 /PRNewswire/ -- Faraday Pharmaceuticals today announced the appointment of Stephen A. Hill, M.D., as Chief Executive Officer. Dr. Hill brings extensive experience across...

Neurocrine Biosciences (NBIX) Announces The Appointment Of Dr. Alfred W. Sandrock To Its Board Of Directors

SAN DIEGO, Sept. 3, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed Alfred W. Sandrock, Jr., M.D., Ph.D. to its Board of Directors effective...

William P. Wall Appointed to STAAR Surgical (STAA) Board Of Directors

MONROVIA, Calif., Sept. 2, 2015 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today...

AMRI (AMRI) Appoints Christopher Conway To Lead AMRI Global Discovery And Development Services Business; Names Vice President Of Discovery Biology And Pharmacology

ALBANY, N.Y., Sept. 3, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) is pleased to announce that it has appointed Christopher Conway as Senior Vice President of Discovery and Development and Global...

InMed Taps Former Altair Therapeutics Exec as President & CEO

InMed Appoints Paul Brennan as President & Chief Executive Officer VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sep 3, 2015) - InMed Pharmaceuticals Inc. ("InMed" or "the...

Daxor Corporation (DXR) Announces Hire Of Senior Vice President, Marketing And Commercial Development

NEW YORK, NY--(Marketwired - September 02, 2015) - Daxor Corporation, (NYSE MKT: DXR), a medical instrumentation and biotechnology company, announced today the appointment of Lisa Quartley as its...

Humacyte, Inc. Appoints The Honorable Kathleen Sebelius And Dale A. Sander To Board Of Directors

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, Inc., a pioneer in biotechnology and regenerative medicine, announced today that former U.S. Secretary of Health and Human Services, Kathleen...

Visterra, Inc. Announces Appointment Of John Weidenbruch As General Counsel

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., a clinical-stage biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel...

Ignyta (RXDX) Appoints Valerie Harding As Senior Vice President, Chemistry, Manufacturing, And Controls

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that Valerie Harding, Ph.D., has been appointed to the newly-created role of...

Precision BioSciences Announces Appointment Of Gene Liau, Ph.D. And Bruce Mccreedy, Ph.D. To Management Team

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, the genome editing company, today announced two key additions to the executive team - Gene Liau, Ph.D., as Senior Vice President,...

Orthodontic Industry Veteran Frank Grunau Named Regional Director Of Europe, Middle East And Africa (EMEA) For OrthoAccel Technologies, Inc.

HOUSTON, Sept. 2, 2015 /PRNewswire/ -- OrthoAccel® Technologies, Inc. announces that orthodontic industry veteran Frank Grunau has joined the company as regional director for Europe, Middle East...

Advanced Clinical Creates Program To Develop New Clinical Research Professionals; Vice President, Clinical Operations Quality And Talent Development Hired To Lead Program

DEERFIELD, IL (September 1, 2015) - Advanced Clinical, a full-service global CRO, functional outsourcing, and strategic staffing solutions provider, announced the creation of Advanced Clinical...

Summit Therapeutics Appoints Ralf Rosskamp, MD, As Chief Medical Officer

OXFORD, United Kingdom, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...